Akero Therapeutics Ownership | Who Owns Akero Therapeutics?
Akero Therapeutics Ownership Summary
Akero Therapeutics is owned by 106.82% institutional investors, 2.54% insiders. Wellington management group llp is the largest institutional shareholder, holding 10.62% of AKRO shares. Vanguard Health Care Inv is the top mutual fund, with 4.59% of its assets in Akero Therapeutics shares.
AKRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Akero Therapeutics | 106.82% | 2.54% | -9.36% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wellington management group llp | 7.38M | 10.62% | $205.23M |
| Rtw investments, lp | 7.42M | 9.43% | $300.33M |
| Blackrock | 5.59M | 9.42% | $131.06M |
| Janus henderson group | 6.03M | 8.69% | $167.77M |
| Blackrock funding, inc. /de | 5.92M | 8.53% | $164.81M |
| General atlantic | 5.23M | 7.54% | $145.61M |
| Price t rowe associates inc /md/ | 4.32M | 6.22% | $120.24M |
| Vanguard group | 3.70M | 5.33% | $103.06M |
| Deep track capital, lp | 3.21M | 4.08% | $129.95M |
| State street | 2.34M | 3.36% | $64.99M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Propel bio management | 228.88K | 10.76% | $9.27M |
| University of wisconsin foundation | 410.63K | 8.30% | $11.42M |
| Foresite capital management vi | 365.00K | 8.09% | $14.78M |
| General atlantic | 5.23M | 5.18% | $145.61M |
| Rtw investments, lp | 7.42M | 4.59% | $300.33M |
| Silverarc capital management | 739.56K | 4.50% | $20.57M |
| Deep track capital, lp | 3.21M | 4.21% | $129.95M |
| Redmile group | 939.28K | 3.59% | $38.02M |
| Exome asset management | 76.38K | 2.75% | $3.09M |
| Logos global management lp | 800.00K | 2.60% | $22.26M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 3.21M | 4.21% | 1.72M |
| Blackrock | 5.59M | 0.00% | 694.02K |
| Rtw investments, lp | 7.42M | 4.59% | 559.52K |
| Morgan stanley | 946.53K | 0.00% | 542.66K |
| Price t rowe associates inc /md/ | 4.32M | 0.01% | 513.61K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alkeon capital management | 1.76M | 0.10% | -1.56M |
| Braidwell lp | - | - | -1.08M |
| Janus henderson group | 6.03M | 0.09% | -1.04M |
| T. rowe price investment management | - | - | -670.05K |
| Balyasny asset management | - | - | -649.13K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sofinnova investments | 510.02K | 1.35% | 510.02K | $20.65M |
| Marshall wace, llp | 275.07K | 0.01% | 275.07K | $7.65M |
| Ikarian capital | 245.00K | 1.22% | 245.00K | $9.92M |
| Stempoint capital lp | 156.19K | 2.02% | 156.19K | $6.32M |
| Soleus capital management | 117.00K | 0.34% | 117.00K | $4.74M |
Sold Out
| Holder | Change |
|---|---|
| Farther finance advisors | -1.00 |
| Newedge advisors | -7.00 |
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Riggs asset managment | -14.00 |
| Continuum advisory | -18.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 198 | 10.00% | 74,179,472 | 1.61% | 106 | 0.97% | 107 | 27.38% | 50 | -12.28% |
| Sep 30, 2024 | 180 | 14.65% | 72,997,386 | 1.71% | 105 | 0.72% | 85 | 8.97% | 57 | 7.55% |
| Jun 30, 2024 | 157 | -15.14% | 71,768,872 | -1.77% | 121 | 0.80% | 78 | -29.09% | 53 | 12.77% |
| Mar 31, 2024 | 185 | 8.82% | 73,065,461 | 23.85% | 123 | 1.10% | 110 | 25.00% | 47 | -2.08% |
| Dec 31, 2023 | 170 | -21.30% | 58,992,846 | 3.30% | 105 | 1.00% | 88 | -29.60% | 48 | 29.73% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 3.66M | 4.59% | -743.67K |
| Vanguard Total Stock Mkt Idx Inv | 2.29M | 3.01% | 166.68K |
| Vanguard US Total Market Shares ETF | 1.94M | 2.55% | 2.50K |
| T. Rowe Price New Horizons | 1.81M | 2.38% | -24.48K |
| US Small-Cap Growth II Equity Comp | 1.81M | 2.38% | 29.50K |
| iShares Russell 2000 ETF | 1.84M | 2.31% | 310.00 |
| Janus Henderson Global Life Sciences | 1.64M | 2.15% | -378.12K |
| Janus Henderson Global Life Sciences D | 1.56M | 2.04% | -68.31K |
| T. Rowe Price Health Sciences | 1.24M | 1.63% | -18.77K |
| Janus Henderson Glb Life Scn I2 USD | 1.26M | 1.58% | -1.16K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 12, 2025 | Cheng Andrew | President and CEO | Sell | $295.20K |
| May 12, 2025 | Cheng Andrew | President and CEO | Sell | $949.26K |
| May 07, 2025 | Lamy Patrick | Senior VP, Commercial Strategy | Sell | $198.89K |
| May 07, 2025 | Lamy Patrick | Senior VP, Commercial Strategy | Sell | $141.06K |
| May 06, 2025 | Rolph Timothy | Chief Scientific Officer | Sell | $379.48K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 15 |
| 2025 Q1 | 4 | 39 |
| 2024 Q4 | - | 31 |
| 2024 Q3 | - | 26 |
| 2024 Q2 | - | 10 |
AKRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools